658 related articles for article (PubMed ID: 21140330)
21. Current status of hepatitis C virus infection in Korea.
Suh DJ; Jeong SH
Intervirology; 2006; 49(1-2):70-5. PubMed ID: 16166792
[TBL] [Abstract][Full Text] [Related]
22. Predicted effects of treatment for HCV infection vary among European countries.
Deuffic-Burban S; Deltenre P; Buti M; Stroffolini T; Parkes J; Mühlberger N; Siebert U; Moreno C; Hatzakis A; Rosenberg W; Zeuzem S; Mathurin P
Gastroenterology; 2012 Oct; 143(4):974-85.e14. PubMed ID: 22863764
[TBL] [Abstract][Full Text] [Related]
23. Ribavirin in the treatment of hepatitis C.
Abonyi ME; Lakatos PL
Anticancer Res; 2005; 25(2B):1315-20. PubMed ID: 15865084
[TBL] [Abstract][Full Text] [Related]
24. Hepatocellular carcinoma in long-term sustained virological responders following antiviral combination therapy for chronic hepatitis C.
Scherzer TM; Reddy KR; Wrba F; Hofer H; Staufer K; Steindl-Munda P; Gangl A; Ferenci P
J Viral Hepat; 2008 Sep; 15(9):659-65. PubMed ID: 18637075
[TBL] [Abstract][Full Text] [Related]
25. Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection.
Hsu CS; Liu CH; Liu CJ; Wang CC; Chen CL; Lai MY; Chen PJ; Chen DS; Kao JH
Am J Gastroenterol; 2009 Mar; 104(3):598-604. PubMed ID: 19262519
[TBL] [Abstract][Full Text] [Related]
26. Approach to the treatment-naïve patient with HCV genotype 1 infection.
Muir AJ
Infect Dis Clin North Am; 2012 Dec; 26(4):893-901. PubMed ID: 23083822
[TBL] [Abstract][Full Text] [Related]
27. Sustained virologic response to antiviral therapy for chronic hepatitis C virus infection: a cure and so much more.
Pearlman BL; Traub N
Clin Infect Dis; 2011 Apr; 52(7):889-900. PubMed ID: 21427396
[TBL] [Abstract][Full Text] [Related]
28. HCV core gene polymorphisms correlate with liver fibrosis but not sustained virological response in patients with genotype 1 infection.
Hsu SJ; Hsu CS; Liu CH; Liu CJ; Chen CL; Chen PJ; Chen DS; Kao JH
Antivir Ther; 2011; 16(2):227-35. PubMed ID: 21447872
[TBL] [Abstract][Full Text] [Related]
29. Chronic hepatitis C virus infection: genotyping and its clinical role.
Bowden DS; Berzsenyi MD
Future Microbiol; 2006 Jun; 1(1):103-12. PubMed ID: 17661689
[TBL] [Abstract][Full Text] [Related]
30. Preparing the patient for success: treat or wait?
Buti M; Esteban R
Dig Liver Dis; 2013 Sep; 45 Suppl 5():S332-6. PubMed ID: 24091112
[TBL] [Abstract][Full Text] [Related]
31. [Chronic hepatitis C infection--eradication of the virus].
Ben Ari Z
Harefuah; 2014 Jul; 153(7):392-3, 433. PubMed ID: 25189028
[TBL] [Abstract][Full Text] [Related]
32. Outcome of antiviral therapy in Egyptian Hepatitis C Virus (HCV) genotype 4 patients with advanced liver fibrosis.
el-Khattib AA; Abdelhakam SM; Ghoraba DM; Ibrahim WA; Sayed MM
Eur J Intern Med; 2012 Jan; 23(1):e34-5. PubMed ID: 22153547
[No Abstract] [Full Text] [Related]
33. Management of hepatitis C virus infection in childhood.
Galoppo M; Galoppo C
Ann Hepatol; 2010; 9 Suppl():98-102. PubMed ID: 20714004
[TBL] [Abstract][Full Text] [Related]
34. Long-term outcome of hepatitis C virus infections acquired after pediatric liver transplantation.
Venturi C; Bueno J; Castells L; Quintero J; Casas I; Allende H; Martinez-Ibañez V; Charco R
Liver Transpl; 2011 Dec; 17(12):1474-80. PubMed ID: 21932378
[TBL] [Abstract][Full Text] [Related]
35. Antiviral activity of the new DAAs for the treatment of hepatitis C virus infection: virology and resistance.
Chevaliez S
Clin Res Hepatol Gastroenterol; 2011 Dec; 35 Suppl 2():S46-51. PubMed ID: 22248694
[TBL] [Abstract][Full Text] [Related]
36. Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C.
Villa E; Karampatou A; Cammà C; Di Leo A; Luongo M; Ferrari A; Petta S; Losi L; Taliani G; Trande P; Lei B; Graziosi A; Bernabucci V; Critelli R; Pazienza P; Rendina M; Antonelli A; Francavilla A
Gastroenterology; 2011 Mar; 140(3):818-29. PubMed ID: 21167831
[TBL] [Abstract][Full Text] [Related]
37. Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection.
Crockett SD; Keeffe EB
Ann Clin Microbiol Antimicrob; 2005 Sep; 4():13. PubMed ID: 16159399
[TBL] [Abstract][Full Text] [Related]
38. [Expert opinion on boceprevir- and telaprevir-based triple therapies of chronic hepatitis C].
Sarrazin C; Berg T; Cornberg M; Dollinger M; Ferenci P; Hinrichsen H; Klinker H; Kraus M; Manns M; Mauss S; Peck-Radosavljevic M; Schmidt H; Spengler U; Wedemeyer H; Wirth S; Zeuzem S
Z Gastroenterol; 2012 Jan; 50(1):57-72. PubMed ID: 22222799
[TBL] [Abstract][Full Text] [Related]
39. Natural history of chronic hepatitis C: genotype 1 versus genotype 6.
Seto WK; Lai CL; Fung J; Hung I; Yuen J; Young J; Wong DK; Yuen MF
J Hepatol; 2010 Sep; 53(3):444-8. PubMed ID: 20554340
[TBL] [Abstract][Full Text] [Related]
40. Impact of HCV genetic differences on pathobiology of disease.
Ripoli M; Pazienza V
Expert Rev Anti Infect Ther; 2011 Sep; 9(9):747-59. PubMed ID: 21905784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
